STOCK TITAN

[Form 4] Omnicell Inc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Randall A. Lipps, Chairman, President and CEO of Omnicell, Inc. (OMCL), reported an internal stock withholding transaction tied to restricted stock unit vesting. The filing shows Mr. Lipps indirectly owns 355,861 shares held in trust with his wife and 8,051 shares held in trust for his children. On 08/15/2025 he had 8,438 shares withheld to cover taxes at a price of $31.69 per share, reducing the reported beneficial ownership to 395,085 shares following the transaction. The form was signed on 08/19/2025 by an attorney-in-fact.

Randall A. Lipps, presidente, CEO e chairman di Omnicell, Inc. (OMCL), ha comunicato un’operazione interna di rinuncia a azioni legata al vesting di restricted stock unit. La comunicazione indica che il sig. Lipps detiene indirettamente 355.861 azioni in trust con la moglie e 8.051 azioni in trust per i figli. In data 15/08/2025 sono state trattenute 8.438 azioni per coprire le imposte al prezzo di $31,69 per azione, riducendo la proprietà beneficiaria dichiarata a 395.085 azioni dopo la transazione. Il modulo è stato firmato il 19/08/2025 da un procuratore legale.

Randall A. Lipps, presidente, CEO y chairman de Omnicell, Inc. (OMCL), informó una retención interna de acciones vinculada al vencimiento de unidades de acciones restringidas. El informe muestra que el Sr. Lipps posee indirectamente 355.861 acciones en fideicomiso con su esposa y 8.051 acciones en fideicomiso para sus hijos. El 15/08/2025 se retuvieron 8.438 acciones para cubrir impuestos a un precio de $31,69 por acción, reduciendo la propiedad beneficiaria declarada a 395.085 acciones tras la operación. El formulario fue firmado el 19/08/2025 por un apoderado.

Randall A. Lipps, Omnicell, Inc. (OMCL)의 회장 겸 사장 겸 CEO는 제한부 주식 단위(Restricted Stock Unit) 베스팅과 관련된 내부 주식 소각(세금 납부를 위한 주식 차감) 거래를 신고했습니다. 신고서에 따르면 Lipps 씨는 배우자와 신탁으로 보유한 355,861주와 자녀들을 위한 신탁으로 보유한 8,051주를 간접적으로 보유하고 있습니다. 2025-08-15에 세금 충당을 위해 8,438주가 주당 $31.69에 차감되어, 거래 후 보고된 실소유 지분은 395,085주로 줄었습니다. 서식은 2025-08-19에 대리인이 서명했습니다.

Randall A. Lipps, président, directeur général et chairman d'Omnicell, Inc. (OMCL), a déclaré une transaction interne de retenue d'actions liée au vesting d'unités d'actions restreintes. Le dépôt indique que M. Lipps détient indirectement 355 861 actions en trust avec son épouse et 8 051 actions en trust pour ses enfants. Le 15/08/2025, 8 438 actions ont été retenues pour couvrir les impôts au prix de $31,69 par action, réduisant la participation bénéficiaire déclarée à 395 085 actions après la transaction. Le formulaire a été signé le 19/08/2025 par un mandataire.

Randall A. Lipps, Chairman, President und CEO von Omnicell, Inc. (OMCL), meldete eine interne Aktieneinbehaltung im Zusammenhang mit dem Vesting von Restricted Stock Units. Die Meldung weist aus, dass Herr Lipps indirekt 355.861 Aktien in einem Trust mit seiner Ehefrau und 8.051 Aktien in einem Trust für seine Kinder hält. Am 15.08.2025 wurden 8.438 Aktien zur Steuerabdeckung einbehalten, zum Preis von $31,69 je Aktie, wodurch das gemeldete wirtschaftliche Eigentum nach der Transaktion auf 395.085 Aktien sank. Das Formular wurde am 19.08.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Disclosure completeness: The Form 4 provides transaction date, amount, price, and clear explanations for holdings and withholding.
  • Ownership transparency: Post-transaction beneficial ownership (395,085 shares) is disclosed along with the nature of indirect holdings (trusts for spouse and children).
Negative
  • None material: The transaction is a tax-withholding disposition; no material negative developments are disclosed in this filing.

Insights

TL;DR: Insider tax-withholding reduced shares by 8,438; ownership remains material and no open-market sale is reported.

The Form 4 discloses a routine withholding of 8,438 shares to satisfy tax obligations from RSU vesting at an indicated per-share price of $31.69. This is recorded as a disposition but reflects internal tax settlement rather than an active cash sale in the market. Post-transaction beneficial ownership stands at 395,085 shares, held indirectly across family trusts. For investors, this is a standard administrative action and does not by itself signal a change in executive intent or company fundamentals.

TL;DR: Disclosure aligns with Section 16 requirements; transaction appears procedural.

The filing identifies Mr. Lipps as both a director and officer and properly reports his indirect holdings and the tax-withholding disposition. The explanation clarifies the withholding was related to RSU vesting. Reporting by attorney-in-fact is documented. This record meets disclosure expectations for insider transactions and shows no unexplained transfers or third-party sales.

Randall A. Lipps, presidente, CEO e chairman di Omnicell, Inc. (OMCL), ha comunicato un’operazione interna di rinuncia a azioni legata al vesting di restricted stock unit. La comunicazione indica che il sig. Lipps detiene indirettamente 355.861 azioni in trust con la moglie e 8.051 azioni in trust per i figli. In data 15/08/2025 sono state trattenute 8.438 azioni per coprire le imposte al prezzo di $31,69 per azione, riducendo la proprietà beneficiaria dichiarata a 395.085 azioni dopo la transazione. Il modulo è stato firmato il 19/08/2025 da un procuratore legale.

Randall A. Lipps, presidente, CEO y chairman de Omnicell, Inc. (OMCL), informó una retención interna de acciones vinculada al vencimiento de unidades de acciones restringidas. El informe muestra que el Sr. Lipps posee indirectamente 355.861 acciones en fideicomiso con su esposa y 8.051 acciones en fideicomiso para sus hijos. El 15/08/2025 se retuvieron 8.438 acciones para cubrir impuestos a un precio de $31,69 por acción, reduciendo la propiedad beneficiaria declarada a 395.085 acciones tras la operación. El formulario fue firmado el 19/08/2025 por un apoderado.

Randall A. Lipps, Omnicell, Inc. (OMCL)의 회장 겸 사장 겸 CEO는 제한부 주식 단위(Restricted Stock Unit) 베스팅과 관련된 내부 주식 소각(세금 납부를 위한 주식 차감) 거래를 신고했습니다. 신고서에 따르면 Lipps 씨는 배우자와 신탁으로 보유한 355,861주와 자녀들을 위한 신탁으로 보유한 8,051주를 간접적으로 보유하고 있습니다. 2025-08-15에 세금 충당을 위해 8,438주가 주당 $31.69에 차감되어, 거래 후 보고된 실소유 지분은 395,085주로 줄었습니다. 서식은 2025-08-19에 대리인이 서명했습니다.

Randall A. Lipps, président, directeur général et chairman d'Omnicell, Inc. (OMCL), a déclaré une transaction interne de retenue d'actions liée au vesting d'unités d'actions restreintes. Le dépôt indique que M. Lipps détient indirectement 355 861 actions en trust avec son épouse et 8 051 actions en trust pour ses enfants. Le 15/08/2025, 8 438 actions ont été retenues pour couvrir les impôts au prix de $31,69 par action, réduisant la participation bénéficiaire déclarée à 395 085 actions après la transaction. Le formulaire a été signé le 19/08/2025 par un mandataire.

Randall A. Lipps, Chairman, President und CEO von Omnicell, Inc. (OMCL), meldete eine interne Aktieneinbehaltung im Zusammenhang mit dem Vesting von Restricted Stock Units. Die Meldung weist aus, dass Herr Lipps indirekt 355.861 Aktien in einem Trust mit seiner Ehefrau und 8.051 Aktien in einem Trust für seine Kinder hält. Am 15.08.2025 wurden 8.438 Aktien zur Steuerabdeckung einbehalten, zum Preis von $31,69 je Aktie, wodurch das gemeldete wirtschaftliche Eigentum nach der Transaktion auf 395.085 Aktien sank. Das Formular wurde am 19.08.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LIPPS RANDALL A

(Last) (First) (Middle)
OMNICELL, INC.
4220 NORTH FREEWAY

(Street)
FORT WORTH TX 76137

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMNICELL, INC. [ OMCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CHAIRMAN, PRESIDENT AND CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 355,861(1) I In Trust with Wife
Common Stock 8,051(2) I In Trust for Children
Common Stock 08/15/2025 F 8,438(3) D $31.69 395,085 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares held in trust with Mr. Lipps' wife.
2. Shares held in trust for the benefit of Mr. Lipps' children.
3. Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
/s/ Vijay Biligiri, Attorney in Fact for Randall A Lipps 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OMCL insider Randall Lipps report on Form 4?

The filing reports a tax-withholding disposition of 8,438 Omnicell shares related to RSU vesting and shows total beneficial ownership of 395,085 shares after the transaction.

When was the transaction reported for OMCL insider activity?

The transaction date is 08/15/2025, and the Form 4 was signed on 08/19/2025.

What price was used for the withheld Omnicell shares?

The withheld shares are reported at a price of $31.69 per share.

Does the Form 4 show any open-market sale by Randall Lipps?

No; the disposition is described as withholding to cover taxes from RSU vesting, not an open-market sale.

How are Mr. Lipps' Omnicell shares held?

Shares are held indirectly: 355,861 in trust with his wife and 8,051 in trust for his children, per the filing.
Omnicell Com

NASDAQ:OMCL

OMCL Rankings

OMCL Latest News

OMCL Latest SEC Filings

OMCL Stock Data

1.46B
45.06M
1.79%
105.73%
4.45%
Health Information Services
Electronic Computers
Link
United States
FORT WORTH